IRCT20220211053992N17招募中Unknown
In vivo fasted-state bioequivalence study of Primidone 125 mg/5ml suspension manufactured by Ashbal shimi Pharmaceutical Co. compared to innovator product
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 59 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
尚未招募
Unknown
In vivo Bioequivalence study of Famotidine tabletIRCT20220211053992N35Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of Famotidine 40 mg tablet.IRCT20210519051345N39Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Evererolimus tabletsIRCT20220211053992N31Tabriz University of Medical Sciences24
招募中
不适用
In vivo Bioequivalence study of peptilock chewable tabletIRCT20210519051345N8Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Emtricitabine/Tenofovir tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N38Tabriz University of Medical Sciences24